RUZALTATUG REZETECAN
UNII QZA4R4JG2Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Ruzaltatug Rezetecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QZA4R4JG2Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2981438-67-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
QZA4R4JG2Z
CAS Registry Number
2981438-67-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RUZALTATUG REZETECAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C202278
National Cancer Institute reference terminology for clinical and research data.
INN ID
13337
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ruzaltatug Rezetecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RUZALTATUG REZETECAN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER3) (HUMAN MONOCLONAL SHR-2008 .GAMMA.1-CHAIN), COMPLEX WITH HUMAN MONOCLONAL SHR-2008 .KAPPA.-CHAIN, DIMER, 215,220,226,229-TETRAKIS(THIOETHER) WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)GLYCYLGLYCYL-L-PHENYLALANYL-N-(((1R)-1-CYCLOPROPYL-2-(((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)-2-OXOETHOXY)METHYL)GLYCINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ERBB3 (RECEPTOR TYROSIN-PROTEIN KINASE ERBB-3, HER3)), HOMO SAPIENS MONOCLONAL ANTIBODY,CONJUGATED ON AN AVERAGE OF FOUR CYSTEINYL RESIDUES TO REZETECAN, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE (EXATECAN) (RUZALTATUG REZETECAN)
RUZALTATUG REZETECAN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus